What is the definitive management of Wolff-Parkinson-White syndrome? _____
Wolff Wolff-Parkinson White (WPW) syndrome: Type A: _____-sided accessory pathway, showing a dominant R wave in lead V1 Type B: right-sided accessory pathway, showing a non-dominant R wave in V1
What is the recommended pharmacological management for a hemodynamically stable Wolff-Parkinson-White (WPW) syndrome patient with atrial fibrillation? _____ or Ibutilide/Flecainide
_____ is an autosommal dominant disorder characterised by left ventricular hypertrophy, impaired diastolic filling, & abnormalities of the mitral valve
The classic ECG triad of _____ syndrome includes a short PR interval, a delta wave (slurred upstroke of QRS), and a widened QRS complex.
Hypertrophic obstructive cardiomyopathy occurs in around 1 in _____
Hypertrophic obstructive cardiomyopathy presents with _____ on auscultation
A patient presents complaining of dyspnoea. Physical exam reveals Kussmaul sign and a pericardial knock on heart auscultation. What is the most likely diagnosis? _____
Flecainide is contraindicated in _____
Myocarditis most commonly presents with _____ then chest pain with a recent history of viral illness
Get full access to all flashcards, spaced repetition, and progress tracking.
Scan to download app